Ketamine for treatment-resistant depression: When and where is it safe?

Ketamine has been used for decades as an anesthetic, and in 2019 an inhaled version of it was approved by the FDA for treatment-resistant depression. But it is generally prescribed only when other treatments have not been effective.

Content restricted. Requires subscription